NephroGenex, Inc. License Agreements
12 Contracts & Agreements
- SECOND AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on April 30, 2015)
- FOURTH AMENDMENT TO LICENSE AGREEMENT between The University of South CarolinaResearch Foundation and NephroGenex, Inc. (assignee of BioStratumIncorporated) (Filed With SEC on January 17, 2014)
- GRANTBACK LICENSE AGREEMENT (Filed With SEC on December 23, 2013)
- AMENDMENTTO LICENSE AGREEMENT between BIOSTRATUM,INCORPORATED and NEPHROGENEX,INC. (Filed With SEC on December 23, 2013)
- FIRSTAMENDMENT TO LICENSE AGREEMENT (Filed With SEC on December 23, 2013)
- RESTATEDand AMENDED LICENSE AGREEMENT Between VANDERBILTUNIVERSITY and NEPHROGENEX,INC. (Filed With SEC on December 23, 2013)
- FIRSTAMENDMENT TO LICENSE AGREEMENT between VanderbiltUniversity and NephroGenex,Inc. (Filed With SEC on December 23, 2013)
- LICENSE AGREEMENT Between VANDERBILT UNIVERSITY and NEPHROGENEX, INC. (Filed With SEC on December 23, 2013)
- LICENSE AGREEMENT BETWEEN THE UNIVERSITY OF SOUTH CAROLINA RESEARCH FOUNDATION AND BioStratum Incorporated USCRF #240, 240.01, 241, and391 USCRF License Agreement # LA 240 241 391 (Filed With SEC on December 23, 2013)
- SECOND AMENDMENT TO AMENDED AND RESTATED LICENSE AGREEMENT between University of Kansas Medical Center ResearchInstitute, Inc. and NephroGenex, Inc. (Filed With SEC on December 23, 2013)
- FIRST AMENDMENT TO AMENDED AND RESTATED LICENSE AGREEMENT between University of Kansas Medical CenterResearch Institute, Inc. and NephroGenex, Inc. (assignee of... (Filed With SEC on December 23, 2013)
- AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on December 23, 2013)
